These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2123529)

  • 1. Treatment of experimental suprachoroidal hemorrhage with subconjunctival injection of tissue plasminogen activator: a negative report.
    Liu JC; Peyman GA; Oncel M
    Ophthalmic Surg; 1990 Sep; 21(9):641-3. PubMed ID: 2123529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental suprachoroidal hemorrhage with intravenous tissue plasminogen activator.
    Liu JC; Peyman GA; Oncel M
    Int Ophthalmol; 1990 Jul; 14(4):267-70. PubMed ID: 2115030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of subconjunctivally injected liposome-encapsulated tissue plasminogen activator on the absorption rate of subconjunctival hemorrhages in rabbits.
    Han SB; Baek SH; Park JS; Yang HK; Kim JY; Kim CK; Hwang JM
    Cornea; 2011 Dec; 30(12):1455-60. PubMed ID: 21955629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of suprachoroidal hemorrhage with tissue plasminogen activator.
    Kwon OW; Kang SJ; Lee JB; Lee SC; Yoon YD; Oh JH
    Ophthalmologica; 1998; 212(2):120-5. PubMed ID: 9486552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of tissue plasminogen activator in experimental filtration surgery.
    Ozment RR; Laiw ZC; Latina MA
    Ophthalmic Surg; 1992 Jan; 23(1):22-30. PubMed ID: 1574262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of subconjunctivally injected, liposome-bound, low-molecular-weight heparin on the absorption rate of subconjunctival hemorrhage in rabbits.
    Moon JW; Song YK; Jee JP; Kim CK; Choung HK; Hwang JM
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3968-74. PubMed ID: 16936112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of tissue plasminogen activator on premacular hemorrhage.
    Chung J; Kim MH; Chung SM; Chang KY
    Ophthalmic Surg Lasers; 2001; 32(1):7-12. PubMed ID: 11195747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive low-dose tissue plasminogen activator for the clearance of experimental vitreous hemorrhage.
    Min WK; Kim YB; Ahn BH; Seong GH
    Korean J Ophthalmol; 1994 Dec; 8(2):45-8. PubMed ID: 7853730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits.
    Ameri H; Kim JG; Ratanapakorn T; Chader GJ; Humayun MS
    Retina; 2008 Feb; 28(2):350-5. PubMed ID: 18301042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy.
    Hesse L; Nebeling B; Schroeder B; Heller G; Kroll P
    Exp Eye Res; 2000 Jan; 70(1):31-9. PubMed ID: 10644418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative use of tissue plasminogen activator for large submacular hemorrhage.
    Chaudhry NA; Mieler WF; Han DP; Alfaro VD; Liggett PE
    Ophthalmic Surg Lasers; 1999 Mar; 30(3):176-80. PubMed ID: 10100249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
    Hassan AS; Johnson MW; Schneiderman TE; Regillo CD; Tornambe PE; Poliner LS; Blodi BA; Elner SG
    Ophthalmology; 1999 Oct; 106(10):1900-6; discussion 1906-7. PubMed ID: 10519583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of experimental vitreous hemorrhage with tissue plasminogen activator.
    Min WK; Kim YB; Lee KM
    Korean J Ophthalmol; 1990 Jun; 4(1):12-5. PubMed ID: 2120486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of tissue plasminogen activator in experimental hyphema.
    Lambrou FH; Snyder RW; Williams GA
    Arch Ophthalmol; 1987 Jul; 105(7):995-7. PubMed ID: 3111453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of subconjunctivally administered tissue plasminogen activator after trabeculectomy.
    Piltz JR; Starita RJ
    Ophthalmic Surg; 1994 Jan; 25(1):51-3. PubMed ID: 8152734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
    Hay SR; Madonna RJ
    Optometry; 2000 Nov; 71(11):715-21. PubMed ID: 11101129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection of cultured autologous fibroblasts into the subconjunctival space of rabbits treated with mitomycin C.
    Hwang JM; Kee C
    Am J Ophthalmol; 2006 Aug; 142(2):259-63. PubMed ID: 16876506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal tissue plasminogen activator treatment of experimental vitreous hemorrhage.
    Johnson RN; Olsen KR; Hernandez E
    Arch Ophthalmol; 1989 Jun; 107(6):891-4. PubMed ID: 2499298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The inhibitory effect of tissue plasminogen activator combined with 5-fluorouracil polyphase liposome on the scar formation in experimental filtration surgery].
    Jing M; Xi S; Chen R
    Zhonghua Yan Ke Za Zhi; 1997 Sep; 33(5):376-80. PubMed ID: 10451987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive, low-dose tissue plasminogen activator for clearance of experimental vitreous hemorrhage.
    Zhao P; Wang W; Song H; Zhu Y
    Yan Ke Xue Bao; 1995 Mar; 11(1):29-31, 40. PubMed ID: 8575602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.